To investigate this hypothesis, we researched the association between the attention network output and clinical measures [that is the cognitive function measured by the Mini‐Mental State Examination (MMSE), CSF beta‐amyloid (Aβ), CSF tau, and polygenic risk scores (PGRS)] in the AD and MCI groups. The gene discussed is MAPT; the disease is Alzheimer disease.